Oncology Fellows
Vol.18-No.2
Volume: 18
Issue: 2
Vol.18-No.1
Volume: 18
Issue: 1
Vol. 17/No. 3
Vol.17/No.4
Volume: 17
Issue: 4
Vol. 17/No. 2
Volume: 17
Issue: 2
Vol. 17/No. 1
Volume: 17
Issue: 1
Vol. 16/No. 4
Volume: 16
Issue: 4
Vol. 16/No. 3
Volume: 16
Issue: 3
Vol. 16/No. 2
Volume: 16
Issue: 2
Vol. 16/No. 1
Volume: 16
Issue: 1
Vol. 15/No. 4
Volume: 15
Issue: 4
Vol. 15/No. 3
Volume: 15
Vol. 15/No. 2
Volume: 14
Vol. 15/No. 1
Volume: 15
Issue: 1
Vol. 14/No. 4
Volume: 14
Issue: 4
Vol. 14/No. 3
Volume: 14
Issue: 3
Vol. 14/No. 2
Volume: 14
Issue: 2
Vol. 14/No. 1
Volume: 14
Issue: 1
Vol. 13/No. 4
Volume: 13
Issue: 4
Vol. 13/No. 3
Volume: 13
Issue: 3
Vol. 13/No. 2
Volume: 13
Issue: 2
Vol. 13/No. 1
Volume: 13
Issue: 1
December 2020
Volume: 12
Issue: 4
September 2020
Volume: 1
Issue: 1
June 2020
Volume: 12
Issue: 2
March 2020
Volume: 12
Issue: 1
December 2019
Volume: 11
Issue: 3
September 2019
Volume: 11
Issue: 3
March 2019
Volume: 11
Issue: 1
June 2019
Volume: 11
Issue: 2
Advertisement
Advertisement
Trending on OncLive
1
European Commission Approves T-DXd Plus Pertuzumab for First-Line HER2+ Metastatic Breast Cancer
2
Dr Huffman on the Mechanism of Action of INCB161734 in KRAS G12D–Mutated Metastatic Pancreatic Cancer
3
MAPKeeper-301 Aims to Confirm the Efficacy of Atebimetinib in Metastatic Pancreatic Cancer
4
ASPEN-09-03 Trial Aims to Build the Case for Evorpacept in Post–T-DXd HER2+ Breast Cancer
5